Experience level:
More than 5 years
Education level:
Higher
Languages:
Russian: Native
English: B2
Over ten years of practical medical experience combined with expertise in medical and market analysis. Successfully applied scientific and commercial knowledge in the pharmaceutical industry to generate insights, bridge clinical needs with business strategy, and enhance competitiveness in a rapidly evolving healthcare environment.
Responsibilities
● Identified strategic gaps and unmet needs through medical research, market and pipeline analysis, followed by interviews with external experts, and reported the results to the Head of R&D.
● Performed feasibility and risk analyses for target drugs for strategic development needs.
● Developed the structure and strategy for a new therapeutic department to improve business efficiency.
Achievements:
● Conducted competitor analysis of 5+ platforms, identified industry trends, and guided product decisions and priorities.
● Based on analytical results, two projects in a new therapeutic area were approved by shareholders and initiated by the R&D team, representing a 60% annual increase in productivity.
● The organizational structure of the new therapeutic area department has been approved and is under data review.
Responsibilities
● Prepared analytical reports on drugs and medical equipment, including medical research and market analysis, forecasting patient flow and sales to support efficient business decisions.
● Provided a full cycle of medical and marketing research to identify and select innovative projects, followed by presenting and defending reports to top management and shareholders.
● Worked directly with various departments to ensure inclusion of acquisition or development ideas for drugs under review.
Achievements:
● Identified 9 innovative projects, 6 of which advanced to financial model development.
● Partnered with medical, R&D, and BU teams to analyze industry trends and pipelines, providing insights that enhanced the strategy for identifying perspective TA/drugs.
● Developed a strategy and interaction scheme between departments at early development and finished product stages, optimizing collaboration between departments. The scheme incorporated into the local SOPs.
Responsibilities:
● Provide 360-degree medical support to the business unit, market access, and GR teams during the pre-launch, launch, and post-launch periods.
● Medical assistance for the development and implementation of marketing product campaigns, as well as assistance in shaping marketing strategies and directions.
● Created strong relationships with KOLs and facilitated the exchange of unbiased scientific information between the medical community and the company.
Achievements:
● Prepared the medical section of the Risankizumab (RZB) dossier for inclusion RZB in the List of Reimbursable Drugs, earning the AbbVie 2021 Presidential Award for Teamwork.
● Coordinated local KOLs’ participation in an international AbbVie project to exchange real-world RZB experience among doctors from different countries.
● Managed the arrival and participation of an international expert at a federal congress session during Covid-19, including negotiations and resolving legal and financial issues. The event was attended online by 3,000+ HCPs and in person by 200+.
Responsibilities:
● Provide medical support to the business unit in fields (area of responsibility – all of Russia).
● Medical maintenance for the development and implementation of marketing product campaigns in fields.
● Foster strong relationships with KOLs and facilitate the exchange of unbiased scientific information between the medical community and company.
Achievements:
● Organized and supported schools of rare disease in pediatric practice, increasing patient detection and drug sales. As a result, in 2018, Firazyr sales by the Russian branch (Shire) were the highest among regional branches.
● Collaborated with geneticists to discover two rare orphan disease mutations new to the Russian Federation.
Achievements:
● Introduced dermatoscopy into routine clinical practice.
● Increased detection of diseases of the oral mucosa.
● Improved early detection rates of malignant skin cancers.
● IQVIA, Midas, Prindex.
● MS Excel, Veeva CRM, MS Outlook, PowerPoint.
● Languages: English (working proficiency).